Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析

◆英語タイトル:Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1591
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Agilent Technologies Inc (A) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises liquid chromatography systems and components, gas chromatography systems and components, microarray solutions, clinical and diagnostic testing, and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, food and other industries. Agilent markets products through direct sales force, distributors, manufacturers’ representatives, resellers and e-commerce. It has research and development and manufacturing facilities in the US, the UK, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc Key Recent Developments

Apr 14,2020 Agilent Technologies provides update on COVID-19 Impact
Mar 31,2020 Agilent introduces new handheld Raw Material ID System for Pharmaceutical Manufacturers
Mar 03,2020 Agilent introduces three new microarrays for prenatal and postnatal research
Feb 18,2020 Agilent reports first quarter fiscal year 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Agilent Technologies Inc – Key Facts
Agilent Technologies Inc – Key Employees
Agilent Technologies Inc – Key Employee Biographies
Agilent Technologies Inc – Major Products and Services
Agilent Technologies Inc – History
Agilent Technologies Inc – Company Statement
Agilent Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Agilent Technologies Inc – Business Description
Business Segment: Agilent CrossLab
Overview
Performance
Key Stats
Business Segment: Diagnostics and Genomics
Overview
Performance
Key Stats
Business Segment: Life Sciences and Applied Markets
Overview
Performance
Key Stats
Geographical Segment: China
Performance
Geographical Segment: Rest of the World
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Agilent Technologies Inc – Corporate Strategy
Agilent Technologies Inc – SWOT Analysis
SWOT Analysis – Overview
Agilent Technologies Inc – Strengths
Agilent Technologies Inc – Weaknesses
Agilent Technologies Inc – Opportunities
Agilent Technologies Inc – Threats
Agilent Technologies Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Agilent Technologies Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Agilent Technologies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 14, 2020: Agilent Technologies provides update on COVID-19 Impact
Mar 31, 2020: Agilent introduces new handheld Raw Material ID System for Pharmaceutical Manufacturers
Mar 03, 2020: Agilent introduces three new microarrays for prenatal and postnatal research
Feb 18, 2020: Agilent reports first quarter fiscal year 2020 financial results
Jan 29, 2020: Agilent teams with Indian Institute of Technology Delhi to enhance Biotherapeutics
Jan 23, 2020: Agilent announces CrossLab Group leadership transition
Jan 16, 2020: Agilent collaborates with university researchers investigating risk factors for eczema
Jan 02, 2020: Agilent expands cross-vendor CDS instrument control
Dec 06, 2019: Agilent ranked among top four best workplaces in greater China and receives certification as a best workplace for women in greater China
Nov 21, 2019: Agilent announces applications open for LabCentral Golden Ticket
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Agilent Technologies Inc, Key Facts
Agilent Technologies Inc, Key Employees
Agilent Technologies Inc, Key Employee Biographies
Agilent Technologies Inc, Major Products and Services
Agilent Technologies Inc, History
Agilent Technologies Inc, Subsidiaries
Agilent Technologies Inc, Key Competitors
Agilent Technologies Inc, Ratios based on current share price
Agilent Technologies Inc, Annual Ratios
Agilent Technologies Inc, Annual Ratios (Cont...1)
Agilent Technologies Inc, Annual Ratios (Cont...2)
Agilent Technologies Inc, Interim Ratios
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Agilent Technologies Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Agilent Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Agilent Technologies Inc, Performance Chart (2015 - 2019)
Agilent Technologies Inc, Ratio Charts
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Agilent Technologies Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CollPlant Ltd (CLGN):医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Holdings Ltd (CollPlant) is a regenerative medicine company that carries out development and commercialization of tissue repair products. The company offers orthobiologics, wound care, and pipeline products. Its orthobiologics products include VergenixSTR and VergenixBVF. CollPlant …
  • Firalis SAS:企業の製品パイプライン分析2018
    Summary Firalis SAS (Firalis) is a biotechnology company that develops biomarkers and biomarker-based diagnostic kits. The company’s biomarker products comprise recombinant proteins and calibrants, Elisa kits, and monoclonal antibodies, among others. It offers biomarker services such as flow cytomet …
  • Smith & Nephew Plc (SN.):医療機器:M&Aディール及び事業提携情報
    Summary Smith & Nephew Plc (Smith & Nephew) is a medical technology company that develops, manufactures and markets medical devices for use in orthopaedic reconstruction and trauma, sports medicines and advanced wound management. The company offers its products in various categories including Sports …
  • Marine Corps Community Services:企業の戦略・SWOT・財務情報
    Marine Corps Community Services - Strategy, SWOT and Corporate Finance Report Summary Marine Corps Community Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Immunodiagnostic Systems Holdings plc (IDH)-医療機器分野:企業M&A・提携分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Protective Life Corporation:企業の戦略・SWOT・財務情報
    Protective Life Corporation - Strategy, SWOT and Corporate Finance Report Summary Protective Life Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nakheel
    Nakheel - Strategy, SWOT and Corporate Finance Report Summary Nakheel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Takeda Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • G. Pohl-Boskamp GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary G. Pohl-Boskamp GmbH & Co KG (Pohl-Boskamp) is a developer of medicines and medical devices. The company offers products which include GeloMyrtol forte, GeloRevoice, GeloSitin Nasenpflege, GeloSitin Nasal Care, GeloBronchial-Saft, GeloDurat-Salbe, GeloDuratInhalator N, Laxopol, Nitrolingual …
  • CSE Global Ltd (544):石油・ガス:M&Aディール及び事業提携情報
    Summary CSE Global Limited (CSE) is a technology company offering process control systems and integrated plant communication systems. It’s process control systems offers emergency shutdown systems, process shutdown systems, integrated control & safety systems and fire and gas detection systems, well …
  • Frequency Electronics Inc:企業の戦略・SWOT・財務分析
    Frequency Electronics Inc - Strategy, SWOT and Corporate Finance Report Summary Frequency Electronics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Abu Dhabi National Oil Co:企業の戦略的SWOT分析
    Abu Dhabi National Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Owensboro Municipal Utilities:企業の戦略的SWOT分析
    Owensboro Municipal Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • PSA Peugeot Citroen S.A. (PSA Groupe):戦略・SWOT・企業財務分析
    PSA Peugeot Citroen S.A. (PSA Groupe) - Strategy, SWOT and Corporate Finance Report Summary PSA Peugeot Citroen S.A. (PSA Groupe) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Hazama Ando Corporation:企業の戦略・SWOT・財務情報
    Hazama Ando Corporation - Strategy, SWOT and Corporate Finance Report Summary Hazama Ando Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • National Oilwell Varco Inc (NOV):石油・ガス:M&Aディール及び事業提携情報
    Summary National Oilwell Varco Inc (NOV) is a provider of technology, equipment, and services to the oil and gas industry. The company’s portfolio of offerings includes rig systems, wellbore technologies, and completion and production solutions. Its product line comprises fiber glass systems, floati …
  • Logitech International S.A. (LOGN):企業の財務・戦略的SWOT分析
    Logitech International S.A. (LOGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Royal Dutch Shell Plc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Royal Dutch Shell Plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Royal Dutch Shell Plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal for …
  • Ildong Pharmaceutical Co Ltd (000230):企業の財務・戦略的SWOT分析
    Summary Ildong Pharmaceutical Co Ltd (IPC) is a manufacturer of pharmaceutical products. The company offers finished drugs, health foods and foods, raw material drugs, cosmetics and medical devices and others. Its raw material drugs comprise synthesis, probiotics, vitamins and biometabolites. IPC al …
  • Assertio Therapeutics Inc (DEPO):製薬・医療:M&Aディール及び事業提携情報
    Summary Assertio Therapeutics Inc (Assertio), formerly Depomed Inc, is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of the central nervous system. Its product portfolio comprises drugs for the treatment of postherpetic neuralg …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆